Baxter Bros Inc. grew its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 9.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 896 shares of the pharmaceutical company’s stock after buying an additional 76 shares during the quarter. […]